We are live on
!
Find out more
First Eagle Investment Management Portfolio holdings
AUM
$59B
1-Year Est. Return
32.99%
This Fund
S&P 500
This Quarter
Est. Return
-0.76%
1 Year Est. Return
+32.99%
3 Year Est. Return
+85.58%
5 Year Est. Return
+122.56%
10 Year Est. Return
+357.65%
AUM
$42B
AUM Growth
-$12.5M
(-0.03%)
Cap. Flow
+$513M
Cap. Flow
% of AUM
1.22%
Top 10 Holdings %
Top 10 Hldgs %
27.1%
Holding
349
New
20
Increased
79
Reduced
89
Closed
33
Top Buys
| 1 |
Danaher
DHR
|
+$220M |
| 2 |
TechnipFMC
FTI
|
+$207M |
| 3 |
B
Barrick Mining
B
|
+$136M |
| 4 |
POT
Potash Corp Of Saskatchewan
POT
|
+$122M |
| 5 |
Royal Gold
RGLD
|
+$121M |
Top Sells
| 1 |
Packaging Corp of America
PKG
|
+$245M |
| 2 |
Elevance Health
ELV
|
+$207M |
| 3 |
Kinross Gold
KGC
|
+$116M |
| 4 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$106M |
| 5 |
AOL
AOL INC COMMON STOCK
AOL
|
+$90.8M |
Sector Composition
| 1 | Financials | 15.59% |
| 2 | Technology | 15.06% |
| 3 | Materials | 13.36% |
| 4 | Industrials | 13.1% |
| 5 | Energy | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRTX
201
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.98M | ﹤0.01% |
62,813
-57,099
| -48% | -$1.68M |
|
202
Summit Therapeutics
SMMT
$12.1B
| $1.94M | ﹤0.01% |
175,000
| – | – |
|
203
Limoneira
LMNR
$249M
| $1.74M | ﹤0.01% |
78,197
| – | – |
|
204
Liberty Broadband Class A
LBRDA
$4.34B
| $1.73M | ﹤0.01% |
34,022
-5,071
| -13% | -$270K |
|
|
MHGC
205
DELISTED
Morgans Hotel Group Co.
MHGC
| $1.52M | ﹤0.01% |
225,000
+25,000
| +13% | +$175K |
|
206
Nuveen Global High Income Fund
JGH
$355M
| $1.5M | ﹤0.01% |
90,000
| – | – |
|
207
IBM
IBM
$206B
| $1.47M | ﹤0.01% |
9,468
| – | – |
|
208
VanEck Junior Gold Miners ETF
GDXJ
$7.07B
| $1.45M | ﹤0.01% |
60,100
| – | – |
|
209
Xylem
XYL
$28.9B
| $1.45M | ﹤0.01% |
39,100
| – | – |
|
210
Murphy Oil
MUR
$4.96B
| $1.43M | ﹤0.01% |
34,477
| – | – |
|
|
AMIC
211
DELISTED
AMERICAN INDEPENDENCE CORP
AMIC
| $1.4M | ﹤0.01% |
148,975
+5,264
| +4% | +$53.6K |
|
212
Novartis
NVS
$289B
| $1.26M | ﹤0.01% |
14,338
| – | – |
|
213
Corcept Therapeutics
CORT
$9.73B
| $1.2M | ﹤0.01% |
+200,000
| New | +$1.23M |
|
|
SHPG
214
DELISTED
Shire pic
SHPG
| $1.17M | ﹤0.01% |
4,830
-289,709
| -98% | -$71.8M |
|
215
Philip Morris
PM
$277B
| $1.11M | ﹤0.01% |
13,800
| – | – |
|
|
AVP
216
DELISTED
Avon Products, Inc.
AVP
| $996K | ﹤0.01% |
159,100
+16,100
| +11% | +$120K |
|
|
ELRC
217
DELISTED
ELECTRO RENT CORP
ELRC
| $969K | ﹤0.01% |
89,200
+500
| +0.6% | +$5.45K |
|
|
LORL
218
DELISTED
Loral Space and Communications, Inc.
LORL
| $947K | ﹤0.01% |
15,000
| – | – |
|
219
Apple
AAPL
$4.62T
| $945K | ﹤0.01% |
30,144
| – | – |
|
220
Medtronic
MDT
$102B
| $944K | ﹤0.01% |
12,735
-924,437
| -99% | -$70.6M |
|
221
MetLife
MET
$59.8B
| $941K | ﹤0.01% |
18,850
| – | – |
|
222
AptarGroup
ATR
$8.21B
| $901K | ﹤0.01% |
14,129
| – | – |
|
223
Bristol-Myers Squibb
BMY
$119B
| $887K | ﹤0.01% |
13,325
-1,167
| -8% | -$76.9K |
|
224
RTX Corp
RTX
$263B
| $887K | ﹤0.01% |
12,712
| – | – |
|
225
Conagra Brands
CAG
$6.8B
| $864K | ﹤0.01% |
25,394
| – | – |
|
Similar funds
NAMI
QCM
